Science Meets Strategy: Adalid Sciences Honored with the Neuron Award for Connecting Science and Business

We are proud to announce that Adalid Sciences has been awarded the prestigious Neuron Award for Connecting Science and Business. Presented during a ceremony at the Prague Planetarium, this honor from the Neuron Foundation celebrates the successful transfer of scientific excellence from the Institute of Organic Chemistry and Biochemistry (IOCB Prague) into a thriving, high-impact commercial venture.

Why This Award Matters

The Neuron Award is not just for scientific discovery—it is specifically for those who have the vision to bring that discovery to the market where it can save lives. For Adalid Sciences, this recognition validates our unique approach to Gene Medicine.

As a spin-off founded by researchers, we have taken a "molecular courier" technology—our second- and third-generation Lipid Nanoparticles (LNPs)—and built a strategic bridge to the pharmaceutical industry.

The "Adalid" Innovation

The award recognizes our development of patented ionizable adamantane-based lipids. Unlike conventional systems, our technology offers:

• Precision Targeting: Delivering therapeutic nucleic acids (mRNA, siRNA, DNA) exactly where they are needed.
• Zero Toxicity: Ensuring safety for patients during long-term treatments.
• Versatile Application: From treating inherited disorders and cancer to the development of next-generation preventive vaccines.

A Message from Our Leadership

"The Neuron Award is a testament to the fact that Czech science is world-class, not just in theory, but in practice. At Adalid Sciences, we are proving that the path from a basic research idea to a preclinical-stage company is one of the most exciting journeys an innovator can take." — Klara Grantz Saskova, CEO

Looking Toward the Horizon

This achievement follows a series of milestones for our leadership team, further solidifying our position as a leader in the European biotech ecosystem. As we move through the preclinical testing phase and expand our discussions with global pharmaceutical partners, we remain committed to our founding mission: to be the champions (Adalids) of scientific progress.

We thank the Neuron Foundation and its patrons for their commitment to fostering a culture where science and business thrive together.

‍